Less frequent genetic causes are linked to infiltrative or metabolic diseases, such as GLA mutations in Fabry disease, TTR in transthyretin amyloidosis, LAMP2 in Danon disease, and PRKAG2 in glycogen storage cardiomyopathy. This evidence concerns the gene GLA and Danon disease.